USA flag logo/image

An Official Website of the United States Government

ARGININE DEIMINASE AS AN ANTI-CANCER THERAPY

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
45601
Program Year/Program:
1999 / SBIR
Agency Tracking Number:
1R43CA078028-01A1
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
PHOENIX PHARMACOLOGICS, INC.
PHOENIX PHARMACOLOGICS, INC. ASTECC FACILITY #A-217 LEXINGTON, KY 40506
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1999
Title: ARGININE DEIMINASE AS AN ANTI-CANCER THERAPY
Agency: HHS
Contract: N/A
Award Amount: $100,492.00
 

Abstract:

Not Available A novel high temperature inductive turbine blade tip clearance sensor is proposed to meet the needs indicated by the Air Force and corroborated by several turbine manufacturers for research and development as well as production applications. The design will meet the goals of measuring tip clearance in gas flows of up to 4000¿F and have a frequency range to measure blade passing up to at least 40 KHz. Clearance measurement range will be up to 0.200 in. with accuracy to 5% of the measured value.

Principal Investigator:

Mike A. Clark

Business Contact:


8592579027
MACLARL@POP.UKY.EDU
Small Business Information at Submission:

PHOENIX PHARMACOLOGICS
ASTECC FACILITY #A-217 UNIVERSITY OF KENTUCKY LEXINGTON, KY 40506

EIN/Tax ID: 232927291
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No